天堂国产午夜亚洲专区-少妇人妻综合久久蜜臀-国产成人户外露出视频在线-国产91传媒一区二区三区

表面修飾唾液酸的唑來膦酸與多柔比星共載脂質(zhì)體的制備

發(fā)布時間:2019-02-17 17:49
【摘要】:目的建立唑來膦酸與多柔比星包封率的測定方法,以包封率為指標(biāo)優(yōu)化唑來膦酸與多柔比星共載脂質(zhì)體的處方及制備工藝,以期獲得包封率高、穩(wěn)定性好的制劑。方法將唑來膦酸配制成銨溶液作為水化介質(zhì),使用改良乙醇注入法制備唑來膦酸脂質(zhì)體,在此基礎(chǔ)上通過銨梯度法主動包載多柔比星以實現(xiàn)兩種藥物在脂質(zhì)體中的共載。分別采用G-150葡聚糖凝膠微柱-高效液相色譜法與陽離子交換纖維微柱-紫外可見分光光度法測定唑來膦酸與多柔比星的包封率,通過對脂質(zhì)體外水相中唑來膦酸的去除及對水化介質(zhì)中陰離子濃度的考察,優(yōu)化脂質(zhì)體的處方與制備工藝。結(jié)果最優(yōu)處方與工藝下制備的共載脂質(zhì)體粒徑約為110 nm,Zeta電位為-0.87 m V,其中唑來膦酸的包封率為6.5%,多柔比星的包封率大于90%。脂質(zhì)體于4℃下避光放置60 d,粒徑和包封率均無顯著性變化,穩(wěn)定性良好。結(jié)論唑來膦酸與多柔比星共載脂質(zhì)體的包封率較高,穩(wěn)定性較好。
[Abstract]:Objective to establish a method for the determination of the entrapment efficiency of zoledronic acid and doxorubicin, and to optimize the formulation and preparation process of liposomes co-loaded with zoledronic acid and doxorubicin with high entrapment efficiency and good stability. Methods Zoledronic acid was prepared into ammonium solution as hydration medium and liposomes were prepared by modified ethanol injection method. Doxorubicin was encapsulated by ammonium gradient method to realize the co-loading of two drugs in liposomes. The encapsulation efficiency of zoledronic acid and doxorubicin was determined by G-150 dextran gel microcolumn and cationic exchange fiber microcolumn UV-visible spectrophotometry, respectively. The formulation and preparation process of liposomes were optimized by the removal of zoledronic acid from the aqueous phase of liposomes and the investigation of anion concentration in hydrated media. Results the particle size of the cocarrier liposomes prepared by the optimal formulation and process was about -0.87mV with a potential of -0.87mV. The entrapment efficiency of zoledronic acid was 6.5, and that of doxorubicin was more than 90m. The particle size and entrapment efficiency of liposomes kept at 4 鈩,

本文編號:2425431

資料下載
論文發(fā)表

本文鏈接:http://www.sikaile.net/yixuelunwen/yiyaoxuelunwen/2425431.html


Copyright(c)文論論文網(wǎng)All Rights Reserved | 網(wǎng)站地圖 |

版權(quán)申明:資料由用戶bbfbf***提供,本站僅收錄摘要或目錄,作者需要刪除請E-mail郵箱bigeng88@qq.com